Sabby Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
– Sell
-2,037,460
Closed -$2.44M – 139
2018
Q4
$2.44M Buy
2,037,460
+418,640
+26% +$811K 0.54% 24
2018
Q3
$3.82M Buy
1,618,820
+308,742
+24% +$770K 0.49% 31
2018
Q2
$3.58M Buy
+1,310,078
New +$3.61M 0.55% 29
2014
Q2
– Sell
-15,944
Closed -$570K – 294
2014
Q1
$570K Buy
+15,944
New +$538K 0.03% 169

Other funds holding ISEE

Sabby Management's ISEE Position: Q1 2019 in Review

Sabby Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q1 2019, closing a stake of 2,037,460 shares — an estimated $2.44M sold.

Sabby Management first reported a position in ISEE in Q1 2014 and held it in 4 quarters. The position peaked at $3.82M in Q3 2018. 58 funds tracked by Wall St. Rank hold ISEE as of Q1 2019.

  • Sabby Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q1 2019 after selling out during the quarter.
  • Sabby Management sold 2,037,460 IVERIC bio, Inc. Common Stock shares in Q1 2019, an estimated $2.44M.
  • Sabby Management first reported a position in IVERIC bio, Inc. Common Stock in Q1 2014 and held it in 4 quarters.
  • Sabby Management's IVERIC bio, Inc. Common Stock position peaked at $3.82M in Q3 2018.
  • 58 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q1 2019.

Based on Sabby Management's 13F filing for Q1 2019, filed 15 May 2019.